Substitution treatment of injecting opioid users for prevention of HIV infection.

@article{Gowing2004SubstitutionTO,
  title={Substitution treatment of injecting opioid users for prevention of HIV infection.},
  author={Linda R Gowing and M Farrell and Reinhard Bornemann and Robert Ali},
  journal={The Cochrane database of systematic reviews},
  year={2004},
  volume={4},
  pages={
          CD004145
        }
}
BACKGROUND Injecting drug users are vulnerable to infection with HIV and other blood borne viruses as a result of collective use of injecting equipment as well as sexual behaviour. OBJECTIVES To assess the effect of oral substitution treatment for opioid dependent injecting drug users on rates of HIV infections, and high risk behaviours. SEARCH STRATEGY Multiple electronic databases were searched. Reference lists of retrieved studies, reviews and conference abstracts were handsearched… 
View on PubMed
globalhealthlearning.org
174 Citations
Highly Influential Citations
7
Background Citations
49
Methods Citations
1
Results Citations
4

174 Citations

Citation Type

Citation Type

Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review.
TLDR
There may be a role for OST in preventing HIV transmission in prisons, but methodologically rigorous research addressing this question specifically is required.
Effectiveness of drug dependence treatment in HIV prevention
nterventions to prevent HIV and Hepatitis C in people who inject rugs: A review of reviews to assess evidence of effectiveness
TLDR
Review-level evidence indicates that harm reduction interventions can reduce IRB, with evidence strongest for OST and NSP, however, there is comparatively little review- level evidence regarding the effectiveness of these interventions in preventing HCV transmission among PWID.
Harm reduction among injecting drug users - evidence of effectiveness
TLDR
There is sufficient review-level evidence that OST reduces HIV transmission, while the evidence in support of NSPs reducing HIV transmission is more tentative, and for DCRs currently insufficient, and an uneven presence of high-quality review evidence.
Change in injecting behaviour among people treated for hepatitis C virus: The role of intimate partnerships
TLDR
Enrolling couples on HCV treatment when partners are sero‐concordant has shown enhanced benefits for reduction in injecting behaviour, and Treating a hard‐to‐reach population for HCV infection is not only possible, but also bears health benefits beyond treatment of HCV alone.
Sex discrepancies in the protective effect of opioid agonist therapy on incident hepatitis C infection.
  • L. Geddes, J. Iversen, +16 authors L. Maher
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2019
TLDR
Female PWID exposed to OAT are twice as likely as their male counterparts to acquire HCV, and structural and behavioural interventions that target women, including affordable housing and safe injection self-efficacy, are required to bolster the efficacy of OAT in preventing HCV transmission.
The effectiveness of opioid maintenance treatment in prison settings: a systematic review.
TLDR
OMT presents an opportunity to recruit problem opioid users into treatment, to reduce illicit opioid use and risk behaviours in prison and potentially minimize overdose risks on release, and if liaison with community-based programmes exists, prison OMT facilitates continuity of treatment and longer-term benefits can be achieved.
Drug Treatment as HIV Prevention: A Research Update
TLDR
The scientific literature leaves no doubt about the effectiveness of drug treatment as an HIV prevention strategy, as drug users in substance abuse treatment are significantly more likely to achieve sustained viral suppression, making viral transmission less likely.
Systematic review research on needle/syringe programs and opiate substitution programs in low- and middle-income countries.
Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions
TLDR
Development and/or implementation of interventions that facilitate women and girls engaging in drug treatment that address their roles within society, work, and family/relationships, and outcome evaluation of these interventions are crucial.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 120 REFERENCES
Risk Factors and Predictors of Human Immunodeficiency Virus Infection among Injection Drug Users
TLDR
Despite the high rate of HCV coinfection in HIV-infected patients, it is found more than 50% of IDUs younger than 23 years to be neither infected with HCV nor with HIV, which should especially focus on young IDUs.
Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
TLDR
MMT may play a significant role in reducing the levels of borrowing of syringes among injecting drug users, but additional prevention measures are needed which should specifically address sexual risk behaviour and target subgroups of IDUs with high levels of needle sharing.
Drug injection cessation among HIV-infected injecting drug users.
Methadone treatment and hiv and hepatitis band C risk reduction among injectiors in the seattle area
TLDR
The results of this study suggest drug use risk reduction is more likely to be achieved by those who remain in drug treatment and byThose who stop injecting, but that those who drop out and return and those who continue to inject while in treatment may also benefit.
Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective.
TLDR
The incidence of HIV remained high among IDUs in Baltimore over the past decade and risk factors for HIV seroconversion differed markedly by sex.
Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
TLDR
Long-term methadone treatment protects against HIV infection, and its effect may be attributable to a reduction in the frequency of injecting drug use or to an increased knowledge of risk factors following counselling in drug centres.
Sex, drugs and HIV counseling and testing: a prospective study of behavior‐change among methadone‐maintenance clients in New England
TLDR
Injecting drug users who self-select to participate in MMTP and HIV C and T, two public health HIV-prevention interventions, reduce their HIV-risk behaviors.
Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs
TLDR
The results suggest the need for taking into account differences between type of HIV-infected drug users and developing appropriate multidrug maintenance treatment programmes, which may imply adaptations of current dosages of methadone and buprenorphine.
HIV infection risks, behaviors and methadone treatment: client-reported HIV infection in a follow-up study of injecting drug users in New England.
TLDR
Findings for IDUs in Massachusetts and Connecticut indicate that risk factors for HIV infection for men are consistent with expected transmission by unclean needles with an HIV-infected partner, but a preference for using speedball predicted HIV infection among women IDUs.
Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study.
TLDR
Among drug users who receive methadone maintenance treatment in a harm-reduction setting, which includes ancillary services such as needle-exchange programmes and HIV testing and counselling, prescription of high methamphetamineadone dosages is not sufficient to stop the spread of HIV, however, an individual increase of the methadon dosage and measures to achieve high treatment retention could contribute to the prevention of HIV among drug users.
...
1
2
3
4
5
...